Satellos management to participate in upcoming investor conferences
Satellos Bioscience Inc. said management will participate in upcoming investor conferences, according to a Globe Newswire announcement.
TORONTO, Sept.
01, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced that management will participate in the following investor conferences…